Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Clinical Trial of Yiqitongluo Granule in the Treatment of Stroke With Qi-deficiency and Blood-stasis Syndrome

NCT02604654 is registered in ClinicalTrials.gov with Yi Yang as lead sponsor.

NCT NCT02604654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02604654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Clinical Trial of Yiqitongluo Granule in the Treatment of Stroke With Qi-deficiency and Blood-stasis Syndrome
Lead sponsor
Yi Yang
Phase
Phase 4
Overall status
Completed
Start date
December 29, 2015
Completion date
December 6, 2017
Enrollment
2,197 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stroke